Value of Contrast (Gd-DTPA)-Enhanced MRI-Studies in Cases of Musculoskeletal Tumors

  • A. M. A. De Schepper
  • H. R. M. Degryse
Part of the Series in Radiology book series (SERA, volume 20)


Gadolinium-DTPA, the contrast medium used in this study, is a complex of the paramagnetic element Gd3+ chelated with DTPA (diethylene-triamine-pentaacetate). The reason for this chelation is to lower the toxicity of Gd itself and to control metabolism and excretion of the metal (1).


Soft Tissue Tumor Contrast Injection Malignant Fibrous Histiocytoma Giant Cell Tumor Fibrous Histiocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Roux E, De Broe L. Contrast agents in magnetic resonance imaging. JBR-BTR 1988; 1: 31–36.Google Scholar
  2. 2.
    Reiser M; Bohndorf K, Niendorf HP, et al. Erste Erfahrungen mit Gadolinium DTPA in der Magnetischen Resonanztomographie (MR) von Knochen- und Weichteiltumoren. Radiologe 1987; 27: 467–472.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • A. M. A. De Schepper
    • 1
  • H. R. M. Degryse
    • 1
  1. 1.Department of RadiologyUniversity Hospital AntwerpBelgium

Personalised recommendations